128 related articles for article (PubMed ID: 14672853)
1. Determinants of weak femoral artery pulse in dogs with mitral valve prolapse.
Tarnow I; Olsen LH; Jensen MB; Pedersen KM; Pedersen HD
Res Vet Sci; 2004 Apr; 76(2):113-20. PubMed ID: 14672853
[TBL] [Abstract][Full Text] [Related]
2. Increased platelet aggregation response in Cavalier King Charles Spaniels with mitral valve prolapse.
Olsen LH; Kristensen AT; Häggström J; Jensen AL; Klitgaard B; Hansson H; Pedersen HD
J Vet Intern Med; 2001; 15(3):209-16. PubMed ID: 11380029
[TBL] [Abstract][Full Text] [Related]
3. Femoral artery occlusion in Cavalier King Charles Spaniels.
Buchanan JW; Beardow AW; Sammarco CD
J Am Vet Med Assoc; 1997 Oct; 211(7):872-4. PubMed ID: 9333089
[TBL] [Abstract][Full Text] [Related]
4. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
[TBL] [Abstract][Full Text] [Related]
5. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
Ljungvall I; Höglund K; Lilliehöök I; Oyama MA; Tidholm A; Tvedten H; Häggström J
J Vet Intern Med; 2013; 27(5):1105-12. PubMed ID: 23865457
[TBL] [Abstract][Full Text] [Related]
6. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
[TBL] [Abstract][Full Text] [Related]
7. Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8- to 10-Year Period.
Birkegård AC; Reimann MJ; Martinussen T; Häggström J; Pedersen HD; Olsen LH
J Vet Intern Med; 2016; 30(1):63-8. PubMed ID: 26578464
[TBL] [Abstract][Full Text] [Related]
8. Myxomatous mitral valve disease in the miniature poodle: A retrospective study.
Meurs KM; Adin D; O'Donnell K; Keene BW; Atkins CE; DeFrancesco T; Tou S
Vet J; 2019 Feb; 244():94-97. PubMed ID: 30825902
[TBL] [Abstract][Full Text] [Related]
9. Utility of Tissue Doppler Imaging in the Echocardiographic Evaluation of Left and Right Ventricular Function in Dogs with Myxomatous Mitral Valve Disease with or without Pulmonary Hypertension.
Baron Toaldo M; Poser H; Menciotti G; Battaia S; Contiero B; Cipone M; Diana A; Mazzotta E; Guglielmini C
J Vet Intern Med; 2016 May; 30(3):697-705. PubMed ID: 27177623
[TBL] [Abstract][Full Text] [Related]
10. Echocardiographic mitral valve prolapse in cavalier King Charles spaniels: epidemiology and prognostic significance for regurgitation.
Pedersen HD; Lorentzen KA; Kristensen BO
Vet Rec; 1999 Mar; 144(12):315-20. PubMed ID: 10212505
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of mitral valve regurgitation in 102 asymptomatic Chinese Crested dogs.
Adler E; Tidholm A
J Vet Cardiol; 2023 Apr; 46():55-61. PubMed ID: 37058906
[TBL] [Abstract][Full Text] [Related]
12. Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease.
Hezzell MJ; Boswood A; Chang YM; Moonarmart W; Elliott J
Am J Vet Res; 2012 Nov; 73(11):1765-74. PubMed ID: 23106462
[TBL] [Abstract][Full Text] [Related]
13. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study.
Pedersen HD; Kristensen BO; Lorentzen KA; Koch J; Jensen AL; Flagstad A
Can J Vet Res; 1995 Oct; 59(4):294-8. PubMed ID: 8548691
[TBL] [Abstract][Full Text] [Related]
14. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Cremer SE; Kristensen AT; Reimann MJ; Eriksen NB; Petersen SF; Marschner CB; Tarnow I; Oyama MA; Olsen LH
Am J Vet Res; 2015 Jun; 76(6):520-31. PubMed ID: 26000599
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Echocardiographic Findings in an Aged Population of Cavalier King Charles Spaniels.
Prieto Ramos J; Corda A; Swift S; Saderi L; De La Fuente Oliver G; Corcoran B; Summers KM; French AT
Animals (Basel); 2021 Mar; 11(4):. PubMed ID: 33800666
[TBL] [Abstract][Full Text] [Related]
16. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
[TBL] [Abstract][Full Text] [Related]
17. Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease.
Mangklabruks T; Surachetpong SD
J Vet Cardiol; 2014 Sep; 16(3):155-62. PubMed ID: 25127665
[TBL] [Abstract][Full Text] [Related]
18. Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study.
Apple SM; Menciotti G; Braz-Ruivo L; Crosara S; Häggström J; Borgarelli M
Aust Vet J; 2016 Sep; 94(9):324-8. PubMed ID: 27569835
[TBL] [Abstract][Full Text] [Related]
19. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration.
Meurs KM; Friedenberg SG; Williams B; Keene BW; Atkins CE; Adin D; Aona B; DeFrancesco T; Tou S; Mackay T
Vet J; 2018 Feb; 232():16-19. PubMed ID: 29428085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
